Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death

International Journal of Cancer

Volumn 110, Issue 4, 2004, Pages 584-588

  Lin, Yingsong ^a   Tamakoshi, Akiko ^b   Kikuchi, Shogo ^a   Yagyu, Kiyoko ^a   Obata, Yuki ^a   Ishibashi, Teruo ^c   Kawamura, Takashi ^d   Inaba, Yutaka ^e   Kurosawa, Michiko ^e   Motohashi, Yutaka ^f   Ohno, Yoshiyuki ^g  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Asama General Hospital   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Asahi Rosai Hospital   (Japan)

Author keywords

IGFBP 3; Nested case control study; Pancreatic cancer; Serum IGF I

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNORADIOMETRIC ASSAY; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

AGED; BODY MASS INDEX; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK;

EID: 2442696659     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20147     Document Type: Article

References (27)

1. Lin Y, Tamakoshi A, Wakai K, Kawamura T, Aoki R, Kojima M, Ohno Y. Descriptive epidemiology of pancreatic cancer in Japan. J Epidemiol 1998;8:52-9.
2. Korc M. Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 1998;7:25-41.
3. Kern S, Hruban R, Hollingsworth MA, Brand R, Adrian TE, Jaffee E, Tempero MA. A white paper: the product of a pancreas cancer think tank. Cancer Res 2001;61:4923-32.
4. Yu H, Rohan T. Role of insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000;92:1472-89.
5. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colerectal cancer risk in men and plasma levels of insulin-like growth factor(IGF)-I and IGF binding protein-3. J Natl Cancer Inst 1999;91:620-5.
6. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 1999;91:151-6.
7. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo, B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 1998;351:1393-6.
8. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-6.
9. McCarty MF. Insulin secretion as a determinant of pancreatic cancer risk. Med Hypotheses 2001;57:146-50.
10. Simpson HL, Umpleby AM, Russell-Jones DL. Insulin-like growth factor and diabetes. A review. Growth Hormone and IGF Res 1998;8: 83-95.
11. Ohno Y, Tamokoshi A. Japan Collaborative Study for Evaluation of Cancer Risk sponsored by Monbusho (JACC study). J Epidemiol 2001;11:144-50.
12. Lin Y. Tamakoshi A, Kawamura T, Inabe Y, Kikuchi S, Motohashi Y, Kurosawa M, Ohno Y. An epidemiological overview of environmental and genetic risk factors of pancreatic caner. Asian Pacific J Cancer Prev 2001;2:271-80.
13. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelson KF, Muller J, Skakkebaek NE. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relations to IGF-I, IGF4-I, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995; 80:2534-42.
14. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller T, Hall K, Skakkebaek NE. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-52.
15. Kama E, Surazynski A, Orlowski K, Laszkiewicz J, Puchalski Z, Nawrat P, Palka J. Serum and tissue level of insulin-like growth factor-I(IGF-I) and IGF-I binding proetein as an index of pancreatitis and pancreatic cancer. Int J Exp Pathol 2002;83:239-45.
16. Evans JD, Eggo MC, Donovan IA, Bramhall SR, Neoptolemos JP. Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein(IGFBP-3) are not elevated in pancreatic cancer. Int J Pancreatol 1997;22:95-100.
17. Bergmann U, Funatomi H, Yokoyama M, Beger, HG, Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995;55:2007-11.
18. Holly JMP, Gunnell DJ, Smith GD. Growth hormone, IGF-I and cancer? Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol 1999;162:321-30.
19. Fisher WE. Diabetes: risk factors for the development of pancreatic cancer or manifestation of the disease? World J Surg 2001;25:503-8.
20. Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res 1996;63:310-3.
21. Clemmons DR. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 1997;8:45-62.
22. Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello L B, Lagiou P, Adami HO, Trichopoulos D. Insulin-like growth factor I and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 1998;90:911-5.
23. Yu H, Jin F, Shu XO, Li B, Dai Q, Cheng JR, Berkel HJ, Zheng W. Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 2002;11:705-12.
24. Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, Kaaks R. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 2002;50:642-6.
25. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E. Serum C-peptide, insulin-like growth factor(IGF)-1, IGF-Binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-1600.
26. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT Jr, Fontana JA. Insulin-like growth factor-binding protein enhancement of insulin-like growth-factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast cancer carcinoma cell line. J Cell Physiol 1994;158:69-78.
27. Haq M, Shaeii AE, Zervos EE, Rosemurgy AS. In vitro and in vivo matrix metalloproteinase production by pancreatic cancer cells and by distant organs. Int J Surg Investig 2000;1:459-65.